Urteste S.A. (WSE:URT)

Poland flag Poland · Delayed Price · Currency is PLN
84.00
-1.00 (-1.18%)
Apr 2, 2025, 3:54 PM CET
-6.67%
Market Cap 119.82M
Revenue (ttm) n/a
Net Income (ttm) -3.37M
Shares Out 1.41M
EPS (ttm) -2.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 265
Average Volume 176
Open 85.00
Previous Close 85.00
Day's Range 81.60 - 85.00
52-Week Range 73.00 - 112.50
Beta 0.17
RSI 36.35
Earnings Date Apr 24, 2025

About Urteste

Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 20
Stock Exchange Warsaw Stock Exchange
Ticker Symbol URT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.